Howland Capital Management Cut Idexx Labs (IDXX) Stake as Market Valuation Declined; Alethea Capital Management Cut Its Pepsico (PEP) Holding by $493,696; Market Value Rose

PepsiCo, Inc. (NASDAQ:PEP) Logo

Alethea Capital Management Llc decreased its stake in Pepsico Inc (PEP) by 63.81% based on its latest 2018Q3 regulatory filing with the SEC. Alethea Capital Management Llc sold 4,408 shares as the company’s stock rose 2.31% while stock markets declined. The institutional investor held 2,500 shares of the consumer non-durables company at the end of 2018Q3, valued at $280,000, down from 6,908 at the end of the previous reported quarter. Alethea Capital Management Llc who had been investing in Pepsico Inc for a number of months, seems to be less bullish one the $161.09B market cap company. The stock increased 0.29% or $0.33 during the last trading session, reaching $114.12. About 2,398 shares traded. PepsiCo, Inc. (NYSE:PEP) has declined 0.46% since February 14, 2018 and is downtrending. It has underperformed by 0.46% the S&P500. Some Historical PEP News: 26/04/2018 – PepsiCo: On Track to Achieve Financial Targets Set Out at Beginning of Year; 14/03/2018 – Amazon, Spotify, The New York Times, DELL, Pepsi Added to Speak at UNLEASH America in Las Vegas in May; 20/04/2018 – PepsiCo Bond Trading 2x Average; Clients Net Sellers; 17/05/2018 – The Malcolm Jenkins Foundation, PepsiCo, and Feed the Children Unite to Defeat Hunger at Get Ready Festâ„¢: Helping Feed Camden, NJ; 25/05/2018 – PepsiCo: Bare Snacks Deal Will Expand Company’s Snacking Portfolio; 26/04/2018 – PepsiCo 1Q Asia, Middle East and North Africa Rev Up 7%; 26/04/2018 – PEPSICO QTRLY NORTH AMERICA BEVERAGES REV WAS DOWN 1 PCT; 26/04/2018 – PepsiCo Sees About $2B Share Repurchases in 2018; 25/05/2018 – PEPSICO ANNOUNCES DEFINITIVE AGREEMENT TO ACQUIRE BARE SNACKS; 26/04/2018 – Pepsi has been trying to turn around its lagging Gatorade business

Howland Capital Management Llc decreased its stake in Idexx Labs Inc (IDXX) by 2.58% based on its latest 2018Q3 regulatory filing with the SEC. Howland Capital Management Llc sold 4,734 shares as the company’s stock declined 20.36% with the market. The institutional investor held 179,081 shares of the health care company at the end of 2018Q3, valued at $44.71M, down from 183,815 at the end of the previous reported quarter. Howland Capital Management Llc who had been investing in Idexx Labs Inc for a number of months, seems to be less bullish one the $18.14 billion market cap company. The stock increased 0.42% or $0.89 during the last trading session, reaching $210.39. About 382,737 shares traded. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has risen 22.67% since February 14, 2018 and is uptrending. It has outperformed by 22.67% the S&P500.

Howland Capital Management Llc, which manages about $1.25 billion and $1.32B US Long portfolio, upped its stake in Core Laboratories N V (NYSE:CLB) by 2,762 shares to 112,865 shares, valued at $13.07 million in 2018Q3, according to the filing. It also increased its holding in Medtronic Plc (NYSE:MDT) by 22,956 shares in the quarter, for a total of 227,755 shares, and has risen its stake in Pimco Etf Tr (MINT).

Since August 21, 2018, it had 1 insider buy, and 8 insider sales for $25.31 million activity. $9.85M worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) was sold by AYERS JONATHAN W. Kingsley Lawrence D bought $501,875 worth of stock. Lane Michael sold $1.44 million worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) on Tuesday, August 21. TWIGGE GIOVANI also sold $208,454 worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) shares. HENDERSON REBECCA M had sold 3,504 shares worth $682,992.

Among 11 analysts covering IDEXX Laboratories (NASDAQ:IDXX), 7 have Buy rating, 2 Sell and 2 Hold. Therefore 64% are positive. IDEXX Laboratories had 35 analyst reports since July 24, 2015 according to SRatingsIntel. Bank of America maintained the shares of IDXX in report on Friday, November 2 with “Buy” rating. The stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) has “Neutral” rating given on Thursday, September 29 by Bank of America. The stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) has “Buy” rating given on Thursday, July 23 by Canaccord Genuity. The stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) earned “Buy” rating by Canaccord Genuity on Monday, January 29. Feltl & Co upgraded it to “Hold” rating and $69.50 target in Friday, July 24 report. The rating was upgraded by C.L. King to “Buy” on Friday, July 28. CL King initiated the shares of IDXX in report on Friday, April 1 with “Neutral” rating. Stifel Nicolaus maintained the stock with “Buy” rating in Thursday, October 29 report. The stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) earned “Outperform” rating by Credit Suisse on Wednesday, April 13. On Monday, October 23 the stock rating was maintained by Stifel Nicolaus with “Buy”.

Investors sentiment increased to 1.04 in Q3 2018. Its up 0.03, from 1.01 in 2018Q2. It increased, as 25 investors sold IDXX shares while 207 reduced holdings. 82 funds opened positions while 159 raised stakes. 70.63 million shares or 1.73% less from 71.88 million shares in 2018Q2 were reported. Korea Investment Corp has invested 0.15% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Meiji Yasuda Asset Mgmt Limited has invested 0.02% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Asset Mgmt One Communications Limited holds 0.08% or 149,039 shares in its portfolio. Conning stated it has 0.01% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX). 5,571 were accumulated by Cubist Systematic Strategies Ltd. Panagora Asset Mngmt stated it has 262,281 shares. Comerica Retail Bank has 0.04% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Weiss Multi invested in 0.01% or 2,008 shares. Invesco Limited has invested 0.1% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Moreover, Quantbot LP has 0.21% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 12,047 shares. Mitsubishi Ufj And Banking Corporation owns 0.06% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 66,109 shares. Wendell David Associate accumulated 30,371 shares. Sumitomo Mitsui Trust accumulated 269,085 shares. Scott And Selber reported 2.2% stake. Nebraska-based Cwm Ltd Llc has invested 0% in IDEXX Laboratories, Inc. (NASDAQ:IDXX).

More notable recent IDEXX Laboratories, Inc. (NASDAQ:IDXX) news were published by: Nasdaq.com which released: “Here’s Why You Should Buy IDEXX Laboratories (IDXX) Stock – Nasdaq” on February 12, 2019, also Nasdaq.com with their article: “ZBH & IDXX Q4 Earnings on Feb 1: Here are the Key Predictions – Nasdaq” published on January 31, 2019, Nasdaq.com published: “Friday 2/8 Insider Buying Report: ADM, IDXX – Nasdaq” on February 08, 2019. More interesting news about IDEXX Laboratories, Inc. (NASDAQ:IDXX) were released by: Seekingalpha.com and their article: “IDEXX: This Medical Equipment Stock Is Overvalued And Could Go Down As Much As 20% – Seeking Alpha” published on May 18, 2018 as well as Nasdaq.com‘s news article titled: “Here’s Why Momentum Investors Will Love Idexx Laboratories (IDXX) – Nasdaq” with publication date: February 13, 2019.

Investors sentiment decreased to 0.87 in 2018 Q3. Its down 0.14, from 1.01 in 2018Q2. It worsened, as 43 investors sold PEP shares while 682 reduced holdings. 129 funds opened positions while 502 raised stakes. 952.72 million shares or 0.70% less from 959.39 million shares in 2018Q2 were reported. Cohen Klingenstein Ltd Liability Corporation has invested 2.24% in PepsiCo, Inc. (NASDAQ:PEP). Reilly Financial Advisors Limited Company, California-based fund reported 97,727 shares. Utah Retirement holds 0.57% in PepsiCo, Inc. (NASDAQ:PEP) or 263,626 shares. 30,303 were accumulated by Girard Limited. Wms Prtn invested 0.48% in PepsiCo, Inc. (NASDAQ:PEP). Valmark Advisers accumulated 5,090 shares. Lau Associates Limited Liability Corp, Delaware-based fund reported 53,420 shares. Oarsman stated it has 0.71% of its portfolio in PepsiCo, Inc. (NASDAQ:PEP). Verition Fund Limited holds 0.14% or 35,453 shares. Lourd Cap Ltd invested 0.04% in PepsiCo, Inc. (NASDAQ:PEP). Finance Advisory Group, Texas-based fund reported 8,944 shares. Tarbox Family Office reported 6,200 shares. Alliancebernstein LP accumulated 5.69 million shares. Hayek Kallen Invest Management reported 2% of its portfolio in PepsiCo, Inc. (NASDAQ:PEP). Carret Asset Mgmt Limited Liability Co holds 1.38% or 79,925 shares in its portfolio.

Since October 4, 2018, it had 0 buys, and 4 selling transactions for $22.66 million activity. Narasimhan Laxman also sold $587,364 worth of PepsiCo, Inc. (NASDAQ:PEP) on Thursday, October 4. Yawman David had sold 12,024 shares worth $1.29 million. Khan Mehmood had sold 168,295 shares worth $18.53M.

Alethea Capital Management Llc, which manages about $155.00M and $66.71 million US Long portfolio, upped its stake in Axsome Therapeutics Inc by 276,620 shares to 547,443 shares, valued at $1.89M in 2018Q3, according to the filing.

Analysts await PepsiCo, Inc. (NASDAQ:PEP) to report earnings on February, 15 before the open. They expect $1.49 earnings per share, up 13.74% or $0.18 from last year’s $1.31 per share. PEP’s profit will be $2.10B for 19.15 P/E if the $1.49 EPS becomes a reality. After $1.59 actual earnings per share reported by PepsiCo, Inc. for the previous quarter, Wall Street now forecasts -6.29% negative EPS growth.

More notable recent PepsiCo, Inc. (NASDAQ:PEP) news were published by: Nasdaq.com which released: “Better Buy: PepsiCo vs. Anheuser-Busch InBev – Nasdaq” on January 26, 2019, also Nasdaq.com with their article: “IWV, PEP, ABBV, AMGN: ETF Outflow Alert – Nasdaq” published on February 11, 2019, Nasdaq.com published: “Pepsico, Inc. (PEP) Ex-Dividend Date Scheduled for December 06, 2018 – Nasdaq” on December 04, 2018. More interesting news about PepsiCo, Inc. (NASDAQ:PEP) were released by: Nasdaq.com and their article: “Agree To Buy PepsiCo At $80, Earn 3.2% Using Options – Nasdaq” published on January 30, 2019 as well as Nasdaq.com‘s news article titled: “PepsiCo Breaks Above 200-Day Moving Average – Bullish for PEP – Nasdaq” with publication date: January 18, 2019.

PepsiCo, Inc. (NASDAQ:PEP) Institutional Positions Chart